Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review 2024: Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type
July 01, 2024 09:52 ET
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...
2022 Parainfluenza Virus Infection Pipeline Insights: Featuring AlloVir, Ansun Biopharma and Moderna Therapeutics
February 08, 2023 13:18 ET
|
Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Parainfluenza Virus Infection - Pipeline Insight, 2022" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Epidemiology Report 2022-2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan
March 09, 2022 06:18 ET
|
Research and Markets
Dublin, March 09, 2022 (GLOBE NEWSWIRE) -- The "Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's...
Global Hospital Infection Therapeutics Market to 2025 by Drug Type, Indication, Value Chain Analysis, Price Analysis
December 09, 2020 06:48 ET
|
Research and Markets
Dublin, Dec. 09, 2020 (GLOBE NEWSWIRE) -- The "Hospital Infection Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...